RNS Number : 5334K
Proximagen Neuroscience Plc
21 April 2010
Proximagen Neuroscience plc (the "Company")
Additional listing
The Company announces that pursuant to the exercise of options under its Unapproved Share Option Plan, it has issued 6,000 ordinary shares of 1p each in the Company ("Ordinary Shares").
The new Ordinary Shares will rank pari passu with the existing Ordinary Shares in the Company. Application has been made to the London Stock Exchange for the Ordinary Shares to be admitted to trading on AIM market for listed securities ("Admission"). It is expected that Admission will become effective at 8.00 a.m. on 26 April 2010.
The total issued share capital of the Company following this issue is 57,302,001 Ordinary Shares.
21 April 2010
Enquiries:
|
Proximagen Neuroscience plc
|
Tel: 020 7848 6938
|
|
James Hunter
|
|
|
|
|
|
Evolution Securities Limited (NOMAD)
|
Tel: 020 7071 4300
|
|
Stuart Andrews, Bobbie Hilliam
|
|
This information is provided by RNS
The company news service from the London Stock Exchange
END
LISPGUPACUPUUMG